Galactooligosaccharides (GOS) inhibit vibrio cholerae toxin binding to its GM1 receptor

Journal of Agricultural and Food Chemistry

Volumn 57, Issue 8, 2009, Pages 3113-3119

  Sinclair, Haydn R ^a,b   De Slegte, Jaap ^a,b   Gibson, Glenn R ^a,b   Rastall, Robert A ^a,b  

^a UNIVERSITY OF READING   (United Kingdom)

^b Royal Friesland Foods ^*  (Netherlands)

Author keywords

Antiadhesive, Vibrio cholerae toxin; Galactooligosaccharide; Glycomimetic; HILIC; Mass spectrometry

Indexed keywords

BETA GALACTOSIDASE; CELL SURFACE RECEPTOR; CHARYBDOTOXIN; CHOLERA TOXIN; GALACTOSE; GANGLIOSIDE RECEPTOR; OLIGOSACCHARIDE;

ARTICLE; BINDING COMPETITION; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; ISOLATION AND PURIFICATION; METABOLISM;

BETA-GALACTOSIDASE; BINDING, COMPETITIVE; CHARYBDOTOXIN; CHOLERA TOXIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; GALACTOSE; OLIGOSACCHARIDES; RECEPTORS, CELL SURFACE;

VIBRIO CHOLERAE;

EID: 65349108712     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf8034786     Document Type: Article

References (41)

1. Kolida, S.; Tuohy, K.; Gibson, G. R. Prebiotic effects of inulin and oligofructose. B. J. Nutr. 2007, 87 (S2), 193-197.
2. Klein, N.; Schwertmann, A.; Peters, M.; Kunz, C.; Strobel, S. Immunomodulatory effects of breast milk oligosaccharides. Adv. EX?. Med. Biol. 2000, 478, 251-259.
3. Zopf, D.; Roth, S. Oligosaccharide anti-infective agents. Lancet 1996, 347 (9007), 1017-1021.
4. Ofek, L; Hasty, D. L.; Sharon, N. Anti-adhesion therapy of bacterial diseases: prospects and problems. FEMS Immunol. Med. Microbiol. 2003, 38 (3), 181-191.
5. Kelly, C. G; Kelly, C. G; Younson, J. S. Anti-adhesive strategies in the prevention of infectious disease at mucosal surfaces. Expert Omn. Invest. Drugs 2000, 9 (8), 1711-1721.
6. Mysore, J. V.; Wigginton, T.; Simon, P. M.; Zopf, D.; Heman-Ackah, L. M.; Dubois, A. Treatment of Helicobacter pylori infection in rhesus monkeys using a novel antiadhesion compound. Gastroenteroloçy 1999, 117 (6), 1316-1325.
7. Coppa, G. V.; Zampini, L.; Galeazzi, T.; Facinelli, B.; Ferrante, L.; Capretti, R.; Orazio, G Human milk oligosaccharides inhibit the adhesion to Caco-2 Cells of diarrheal pathogens: Escherichia coli, Vibrio cholerae, and Salmonella fyris. Pediatr. Res. 2006, 59 (3), 377-382.
8. Thomas, R. J.; Brooks, T. J. Oligosaccharide receptor mimics inhibit Legionella pneumophila attachment to human respiratory epithelial cells. Microb. Pathol. 2004, 36 (2), 83-92.
9. Lanne, B.; Schierbeck, B.; Angstrom, J. Binding of cholera toxin B-subunits to derivatives of the natural ganglioside receptor, GM1. J. Biochem. (Tokyo) 1999, 126 (1), 226-234.
10. Sixma, T. K.; Pronk, S. E.; Kalk, K. H; Wartna, E. S.; van Zanten, B. A.; Witholt, B.; Hoi, W. G Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli. Nature 1991, 351 (6325), 371-377.
11. -investigation by molecular modeling and molecular mechanics. J. Biomol. Struct. Dyn. 2004, 21 (4), 591-614.
12. Merritt, E. A; Zhang, Z.; Pickens, J. C; Ahn, M.; Hol, W. G; Fan, E. Characterization and crystal structure of a high-affinity pentavalent receptor-binding inhibitor for cholera toxin and E. coli heat-labile enterotoxin. J. Am. Chem. Soc. 2002, 124, 8818-8824.
13. Schengrund, C. L.; Ringler, N. J. Binding of Vibrio cholera toxin and the heat-labile enterotoxin of Escherichia coli to GM1, derivatives of GM1, and nonlipid oligosaccharide polyvalent ligands. J. Biol. Chem. 1989, 264 (22), 13233-13237. [published erratum appears in J. Biol. Chem. 1989, 264 (31), 18853].
14. Pacuszka, T.; Bradley, R. M.; Fishman, P. H. Neoglycolipid analogues of ganglioside GM1 as functional receptors of cholera toxin. Biochemistry 1991, 30, 2563-2570.
15. Minke, W. E.; Roach, C; Hol, W. G J.; Verlinde, C. Structure-based exploration of the ganglioside GM1 binding sites of Escherichia coli heat-labile enterotoxin and cholera toxin for the discovery of receptor antagonists. Biochemistry 1999, 38, 5684-5692.
16. Garg, P.; Chakraborty, S.; Basu, L; Datta, S.; Rajendran, K.; Bhattacharya, T.; Yamasaki, S.; Bhattacharya, S. K.; Takeda, Y.; Nair, G. B.; Ramamurthy, T. Expanding multiple antibiotic resistance among clinical strains of Vibrio cholerae isolated from 1992-7 in Calcutta, India. Epidemiol. Infect. 2000,124 (3), 393-399.
17. Wallenfels, K.; Malhotra, O. P. Galactosidases. Adv. Carbohvdr. Chem. 1961, 16, 239-298.
18. Matsumoto, K.; Kobayashi, Y.; Uuima, S.; Watanabe, T.; Tanaka, R.; Kan, T; Akio, K.; Sumihara, S. Galactooligosaccharides. In Oligosaccharides: Production, Properties and Applications; Na-kakuki, T. Eds.; Gordon and Breach Science Publishers: Shizuoka, Japan, 1995; pp 90-106.
19. Smith, P. K.; Krohn, R. L; Hermanson, G. T; Mallia, A. K.; Gartner, F. H.; Provenzano, M. D.; Fujimoto, E. K.; Goeke, N. M.; Olson, B. J.; Klenk, D. C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 1985, 150 (1), 76-85.
20. Keisuke, M. K.; Tamura, N. T. Method for producing galactoo- hgosaccharide. Eur. Patent EP0272095, 1988.
21. Sinclair, H. R.; Smejkal, C. W.; Glister, C; Kemp, C; van den Heuval, E.; de Slegte, J.; Gibson, G R.; Rastall, R. A. Sialylo-ligosaccharides inhibit cholera toxin binding to GM1 receptor. Carbohvdr. Res. 2008, 343 (15), 2589-2594.
22. Dawson, R. M. Characterization of the binding of cholera toxin to ganghoside GM1 immobilized onto microtitre plates. J. APPI. Toxicol. 2005, 25 (1), 30-38.
23. Liu, Y.; Urgaonkar, S.; Verkade, J. G.; Armstrong, D. W. Separation and characterization of underivatized oligosaccharides using liquid chromatography and liquid chromatography- electrospray ionization mass spectrometry. J. Chromatoer. A 2005, 1079 (1-2), 146-152.
24. Fausnaugh-Pollitt, J.; Thevenon, G.; Janis, L.; Regnier, F. E. Chromatographic resolution of lysozyme variants. J. Chromatoer. 1988, 443, 221-228.
25. Alpert, A. J.; Shukla, M.; Shukla, A. K.; Zieske, L. R.; Yuen, S. W.; Ferguson, M. A.; Mehlert, A.; Pauly, M.; Orlando, R. Hydrophilic-interaction chromatography of complex carbohydrates. J. Chromatogr., A 1994, 676 (1), 191-122.
26. Harvey, D. J. Quantitative aspects of the matrix-assisted laser desorption mass spectrometry of complex oligosaccharides. Rapid Commun. Mass Spectrom. 1993, 7 (7), 614-619.
27. Lamari, F. N.; Kuhn, R.; Karamanos, N. K. Derivatization of carbohydrates for chromatographic, electrophoretic and mass spectrometric structure analysis. J. Chromatoçr. B: Anal. Technol. Biomed. Life Sci. 2003, 793 (1), 15-36.
28. Naidong, W. Bioanalytical liquid chromatography tandem mass spectrometry methods on underivatized silica columns with aqueous/organic mobile phases. J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2003, 796 (2), 209-224.
29. Burlingame, A. L.; Boyd, R. K.; Gaskell, S. J. Mass spectrometry. Anal. Chem. 1994, 66, 634R-683R.
30. Lin, S.; Lee, W. Separation of a fructo-oligosaccharide mixture by hydrophilic interaction chromatography using silica-based micropellicular sorbents. J. Chromatoçr. 1998, 803 (1- 2), 302-306.
31. Tolstikov, V. V.; Fiehn, O. Analysis of highly polar compounds of plant origin: combination of hydrophilic interaction chromatography and electrospray ion trap mass spectrometry. Anal. Biochem. 2002, 301 (2), 298-307.
32. Grumbach, E. S.; Wagrowski-Diehl, D. M.; Mazzeo, J. R.; Alden, B.; Iraneta, P. C. Hydrophilic interaction chromatography using silica columns for the retention of polar analytes and enhanced ESI-MS sensitivity. LCGC North Am. 2004, 22 (10), 1010-1023.
33. Ballance, S.; Aarstad, O. A.; Aachmann, F. L.; Skjåk-Braek, G.; Christensen, B. E. Preparation of high purity monodisperse oligosaccharides derived from mannuronan by size-exclusion chromatography followed by semi-preparative high-performance anion-exchange chromatography with pulsed amperometric detection. Carbohvdr. Res. 2009, 344 (2), 255-259.
34. Cuatrecasas, P. Vibrio cholerae choleragenoid. Mechanism of inhibition of cholera toxin action. Biochemistry 1973, 12, 3577-3581.
35. Turnbull, W. B.; Precious, B. L.; Homans, S. W. Dissecting the cholera toxin-ganglioside GM1 interaction by isothermal titration calorimetry. J. Am. Chem. Soc. 2004, 126, 1047-1054.
36. Schon, A.; Freire, E. Thermodynamics of intersubunit interactions in cholera toxin upon binding to the oligosaccharide portion of its cell surface receptor, ganglioside GM1. Biochemistry 1989, 28, 5019-5024.
37. Otnaess, A. B.; Laegreid, A.; Ertresvåg, K. Inhibition of entero-toxin from Escherichia coli and Vibrio cholerae by gangliosides from human milk. Infect. Immun. 1983, 40 (2), 563-569.
38. Holmgren, J.; Svennerholm, A. M.; Ahrâen, C. Nonimmunoglo-bulin fraction of human milk inhibits bacterial adhesion (hemag-glutination) and enterotoxin binding of Escherichia coli and Vibrio cholerae. Infect. Immun. 1981, 33 (1), 136-141.
39. Idota, T.; Kawakami, H. Inhibitory effects of milk gangliosides on the adhesion of Escherichia coli to human intestinal carcinoma cells. Biosci. Biotechnol. Biochem. 1995, 59 (1), 69-72.
40. Shoaf, K.; Mulvey, G. L.; Armstrong, G. D.; Hutkins, R. W. Prebiotic galactooligosaccharides reduce adherence of entero-pathogenic Escherichia coli to tissue culture cells. Infect. Immun. 2006, 74 (12), 6920-6928.
41. Branderhorst, H. M.; Liskamp, R. M. J.; Visser, G. M.; Pieters, R. J. Strong inhibition of cholera toxin binding by galactose dendrimers. Chem. Commun. 2007, 47, 5043-5045.